EDWARD CAPPARELLI: Open Payments
NPI 1275504326 · ONEIDA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 6 payments from 6 companies in 2025. Trend: 2023 $611 · 2024 $239 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $112 |
| Averitas Pharma Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: VIVITROL, QUTENZA, VRAYLAR, CAPLYTA, AIRSUPRA, Veozah.
Industry payments across TN — which companies pay providers there.
